RSS-Feed abonnieren
DOI: 10.1055/s-1991-26380
A Facile Method for the Side-Chain Protection of α-Methyl-β-3, 4-dihydroxyphenyl-L-alanine (αMeDopa) for Solid-Phase Peptide Synthesis
Publikationsverlauf
Publikationsdatum:
17. September 2002 (online)
![](https://www.thieme-connect.de/media/synthesis/199101/lookinside/thumbnails/10.1055-s-1991-26380-1.jpg)
Two approaches have been used to prepare N α-tert-butoxycarbonyl-α-methyl-β-3,4-dimethoxy-, or dibenzyloxyphenyl-L-alanine, N α-Boc-α-MeDopa(R)2, where R is the methyl or benzyl ether. In the first approach, α-methyl-β-3,4-dihydroxyphenyl-L-alanine (αMeDopa) is reacted with di-tert-butyl dicarbonate (Boc2O) in the presence of sodium bicarbonate under anhydrous conditions. The resultant N-protected derivative (Boc-αMeDopa) is methylated with methyl iodide/sodium carbonate, followed by reaction with methyl iodide/tetramethylammonium hydroxide, and saponification with potassium hydroxide in aqueous dioxane to give N α-tert-butoxycarbonyl-α-methyl-β-3,4-dimethoxyphenyl-L-alanine, Boc-αMeDopa(Me)2, in 30% overall yield. In the second approach, methyl ester of α-methyl-β-3,4-dihydroxyphenyl-L-alanine is prepared by the thionyl chloride/methanol procedure, followed by N-protection with di-tert-butyl dicarbonate/sodium bicarbonate, sidechain protection with benzyl chloride/tetramethylammonium hydroxide, and saponification with sodium hydroxide in aqueous dioxane to give N α-tert-butoxycarbonyl-α-methyl-β-3,4-dibenzyloxyphenyl-L-alanine, Boc-αMeDopa(CH2Ph)2, in 46% overall yield. The latter derivative has been incorporated into angiotensin II under stepwise solid-phase peptide synthesis and solution coupling conditions.